Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity

Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.

Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.

Dr. Soon-Shiong delves into some of his reasoning for the ImmunityBio vaccine candidate's particular orientation toward the immune system.

Related Content:

RESPIRATORY INFECTIONSCORONAVIRUSVACCINESCOVID VACCINE RACE
Investigational Vaccine Meets RSV Inoculation Challenge
HIV Testing and Diagnoses Drop During COVID-19 Pandemic
How COVID-19 Infiltrates and Inflames the Heart